Diabetes, Metabolic Syndrome and Obesity
Metabolic Disorders and Complications
Section Editor(s): Professor Sull, Department of Biomedical Laboratory Science, School of Health Sciences, Eulji University, Seongnam, KoreaThis section welcomes submissions on a wide range of topics related to obesity and diabetes related metabolic disorders and complications. This includes, but is not limited to, the metabolic syndrome, insulin resistance, hypertension, non-alcoholic fatty liver disease, metabolic dysfunction-associated steatotic liver disease, gestational diabetes, and cardiovascular disease. Studies on the relationship of diabetes, metabolic syndrome or obesity in relation to malignancies are also welcome.
Latest articles in Metabolic Disorders and Complications:
- 25 records -
Incorporating Insulin Resistance Biomarkers into Machine Learning Models Enhances Diagnostic Accuracy for Metabolic Dysfunction–Associated Steatotic Liver Disease
Nie J, Zhou J, Hu Y, Zhang C, Yu P, Lei X
Diabetes, Metabolic Syndrome and Obesity 2026, 19:590383
Published Date: 4 June 2026
Clinical Outcomes and Safety of Stem Cell Therapy for Diabetic Foot Ulcers: A Cross-Sectional Analysis of Overlapping Meta-Analyses
Du Y, Xu Z, Wen T, Meng X, Zhang B, Gao Q, Zhao X, Jia Z
Diabetes, Metabolic Syndrome and Obesity 2026, 19:593437
Published Date: 27 May 2026
Association of Euthyroid Thyroid Hormone Levels with Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease
Oral A, Çavuşoğlu Türker B, Anılır E, Şahin T, Koçak E, Türker F
Diabetes, Metabolic Syndrome and Obesity 2026, 19:555563
Published Date: 23 May 2026
Inhibition of TWEAK/Fn14 Ameliorates Sarcopenic Obesity by Restoring Mitochondrial Biogenesis via the AMPK/SIRT1/PGC-1α Axis
Xuekelati S, Maimaitiwusiman Z, Guo Y, Guo S, Xu Q, Ke J, Xu L, Yang Y, Wang H
Diabetes, Metabolic Syndrome and Obesity 2026, 19:596507
Published Date: 18 May 2026
Chromium as a Modulator of Insulin Receptor Activity: A Systematic Review of Its Role in Metabolic Syndrome and Type 2 Diabetes
Babakr AT, Mukhtar MH, Ali ASE, Althubiti MA, Modawe GA, Fatani SH, Nasif WA
Diabetes, Metabolic Syndrome and Obesity 2026, 19:581925
Published Date: 15 May 2026
Telomere Length in Metabolic Syndrome: Mechanisms, Epidemiology and Clinical Implications: A Narrative Review
Cilia K, Gauci Z, Agius R, Fava S, Pace NP
Diabetes, Metabolic Syndrome and Obesity 2026, 19:604828
Published Date: 8 May 2026
Sex Differences in the Prevalence and Associated Factors of Metabolic Syndrome: A Cross-Sectional Study of University Employees in China
Jiang XH, Yu Q, Yang W
Diabetes, Metabolic Syndrome and Obesity 2026, 19:586568
Published Date: 8 May 2026
Cumulative Triglyceride-Glucose Index and Risk of Metabolic Dysfunction–Associated Fatty Liver Disease: Findings from the Kailuan Cohort
Zhang C, Zhang Z, Qi Q, Li L, Deng J, Zheng J, Jiang Y, Han Q, Wu S, Li K
Diabetes, Metabolic Syndrome and Obesity 2026, 19:570754
Published Date: 1 May 2026
Gender-Specific Predictive Utility of Twelve Anthropometric Indices for Metabolic Syndrome in Chinese Lahu Adults with Dyslipidemia
Chen J, Guo W, Yin H, Li H
Diabetes, Metabolic Syndrome and Obesity 2026, 19:593804
Published Date: 9 April 2026
Sleeve Gastrectomy Alters Exosomal miR-497-5p Cargo to Ameliorate Metabolic Dysfunction–Associated Steatotic Liver by Targeting GABARAPL1
Li Z, Tian C, Wang M, Li Z, Wang L, Wang Z, Yu C, Wang D, Lian D, Zhang N
Diabetes, Metabolic Syndrome and Obesity 2026, 19:568182
Published Date: 9 April 2026
Determinants of Liver Steatosis Progression in Chinese Children: A Prospective Cohort Study
Wang Y, Tang C, Yang P, Zheng X, Zhu L, Zhang H, Zhang L, Zheng Q
Diabetes, Metabolic Syndrome and Obesity 2026, 19:594442
Published Date: 9 April 2026
Peripapillary Retinal and Choroidal Vasculature in Patients with Diabetes of Different Durations without Clinical Diabetic Retinopathy
Yan M, Zhang WJ, Chen C, Huang Z, Ye Y, Xu DQ, Deng YM, Song YP
Diabetes, Metabolic Syndrome and Obesity 2026, 19:563069
Published Date: 9 April 2026
Correlation Between the Thyroid Hormone Levels and Type 2 Diabetes Mellitus in Non-Alcoholic Fatty Liver Disease
Bian L, Fan H, Yu Q, Rao X, Tang T, Feng L, Shi YY, Tong X, Zhang X, Tang J, Zhang P, Wang M, Qu X
Diabetes, Metabolic Syndrome and Obesity 2026, 19:577491
Published Date: 23 March 2026
Fasting Metabolite Panel for OGTT-Free Diagnosis of Gestational Diabetes Mellitus: A Machine Learning Approach Validated in Dual Cohorts
Yin B, Shen Y, Zhang Q, Chen R, Zhang X, Kong Z, Zhu Y
Diabetes, Metabolic Syndrome and Obesity 2026, 19:572688
Published Date: 13 March 2026
Extended Oral Glucose Tolerance Test Unmasks Intermediate Metabolic Phenotypes in Polycystic Ovary Syndrome
Wang S, Gao X, Li F
Diabetes, Metabolic Syndrome and Obesity 2026, 19:593979
Published Date: 7 March 2026
Association Between Platelet Parameters and Metabolic Syndrome in Residents of Wuhu, China: A Mediation Analysis of Insulin Resistance
Zhou L, Wu H, Wu T, Wang X, Song E, Su F, Ezeokafor CA, Wu Y, Ma X, Wang T, Wen Y
Diabetes, Metabolic Syndrome and Obesity 2026, 19:575645
Published Date: 12 February 2026
Comment on: “Association of Fasting C-Peptide to High Density Lipoprotein Cholesterol Ratio with Non-Alcoholic Fatty Liver Disease in Chinese Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study” [Letter]
Hu K, Xu H
Diabetes, Metabolic Syndrome and Obesity 2026, 19:590804
Published Date: 24 January 2026
The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction–Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status
Li L, Cong C, Zhang X, Zhang X
Diabetes, Metabolic Syndrome and Obesity 2026, 19:573711
Published Date: 23 January 2026
Markers Of Insulin Resistance and Their Clinical Implications In Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Albai O, Braha A, Timar R, Lazar S, Popescu S, Timar B
Diabetes, Metabolic Syndrome and Obesity 2026, 19:577797
Published Date: 19 January 2026
Dynamic Alterations of BMP9 in NAFLD: A Novel Hepatokine Marker of Metabolic Dysfunction and Disease Severity
Cui F, Chen F, Dong F, Dong J
Diabetes, Metabolic Syndrome and Obesity 2026, 19:552791
Published Date: 8 January 2026
Association of the Triglyceride Glucose Index and Epicardial Adipose Tissue with Type 2 Diabetes Mellitus Complicated by Coronary Atherosclerotic Heart Disease
Liu B, Du J, Niu Z, Lu Q
Diabetes, Metabolic Syndrome and Obesity 2026, 19:566381
Published Date: 8 January 2026
Prevalence of Metabolic Syndrome in Iran: An Umbrella Review Across Diagnostic Criteria and Population Subgroups
Sepandi M, Taghdir M, Alimohamadi Y
Diabetes, Metabolic Syndrome and Obesity 2026, 19:578458
Published Date: 8 January 2026
Prevalence and Correlates of Dumping Syndrome After Bariatric Surgery in Saudi Adults: The Role of Social Determinants and Nutrition Knowledge
Baghdadi LR, Aloraini HK, Almohanna RA, Alhazmi JI, Alhalafi FM, Alotaebe SH
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4831-4842
Published Date: 30 December 2025
Nano-Enhanced Diets: Advancing Metabolic Dysfunction-Related Steatotic Liver Disease (MASLD) – A Review
Herdiana Y
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4715-4731
Published Date: 23 December 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis are Associated with Advanced Cardiovascular-Kidney-Metabolic Syndrome in Chinese and US Populations
Hu S, Wang D, Yu Q, Chen Z, Lu W, Meng Y, Peng X, Liu L, Wan H, Shen J
Diabetes, Metabolic Syndrome and Obesity 2025, 18:4699-4713
Published Date: 23 December 2025